0001209191-20-009447.txt : 20200213 0001209191-20-009447.hdr.sgml : 20200213 20200213200014 ACCESSION NUMBER: 0001209191-20-009447 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200211 FILED AS OF DATE: 20200213 DATE AS OF CHANGE: 20200213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jaffe Matthias CENTRAL INDEX KEY: 0001752457 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 20613032 MAIL ADDRESS: STREET 1: 610 MAIN STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 99 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-11 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001752457 Jaffe Matthias 99 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 7.11 2020-02-11 4 A 0 69000 0.00 A 2030-02-11 Common Stock 69000 69000 D 25% vests on 01/01/2021 and the remainder vests in equal monthly installments over the next 36 months. /s/ Matthias Jaffe 2020-02-13